ArticleInternational journal of women's health2026
Gestational Diabetes in Somali Women: Neglected Risks for Maternal and Neonatal Health.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This commentary examines gestational diabetes mellitus (GDM) as an under-recognised contributor to adverse maternal and neonatal outcomes among Somali women and in comparable fragile settings. GDM is associated with pre-eclampsia, macrosomia, obstructed labour, stillbirth, neonatal morbidity, and later type 2 diabetes in women and offspring. Globally, hyperglycaemia in pregnancy affects approximately one in six live births, yet detection and management remain least accessible in low-resource and conflict-affected settings. Somalia has high maternal and neonatal mortality, but local GDM prevalence data are not available and routine screening is rarely embedded in antenatal care. Drawing on WHO guidance, international evidence, and literature on Somali, East African, migrant, and humanitarian populations, we argue that GDM is made invisible by overlapping clinical, social, and health-system factors: early-life undernutrition, nutritional transition, high fertility, short birth intervals, limited antenatal access, weak diagnostic supply chains, low awareness of asymptomatic "sugar disease", and limited policy attention to pregnancy-related non-communicable diseases. These gaps convert a detectable and manageable condition into preventable complications, including obstructed labour, postpartum haemorrhage, hypertensive disorders, stillbirth, neonatal hypoglycaemia, and intergenerational diabetes risk. Practical responses include pragmatic risk-based or simplified glucose screening where oral glucose tolerance testing is not feasible, reliable access to glucometers and strips, midwife-led protocols, Somali-language education, engagement of families and community leaders while protecting women's autonomy, postpartum follow-up linked to immunisation and child-health contacts, and inclusion of GDM indicators in maternal health information systems. Recognising and addressing GDM is essential for reducing preventable maternal and neonatal harm and for strengthening equitable women's healthcare in fragile settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.